Nikola Trbovic, PHD is Executive Director, WRDM and Partner at Pfizer Ventures. Nikola is responsible for identifying, evaluating, making and managing equity investments aligned with the future directions of Pfizer. He currently has responsibility for Pfizer’s investments in Arrakis, Artios, Cydan, Jnana, Lodo, Mediar, Nimbus, Palleon, TRex, and Triplet.
Prior to his current role, Nikola held responsibilities for R&D technology investments, R&D strategy and early clinical portfolio management in Worldwide Research & Development at Pfizer. Nikola joined Pfizer from McKinsey Co., where he served as an Associate Principal and senior member of the Pharmaceuticals Practice, advising top pharmaceutical, biotech, and healthcare companies on a range of strategy, corporate finance and commercial topics across geographies and therapeutic areas.
Nikola received a BS in Biochemistry from the University of Frankfurt, Germany, and holds a PhD in Biochemistry and Molecular Biophysics from Columbia University.